Article
Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies
Registro en:
CARVALHO, A. M. et al. Interleukin 10-dominant immune response and increased risk of Cutaneous Leishmaniasis after natural exposure to Lutzomyia intermedia Sand Flies. Journal of Infectious Diseases, fevereiro 2015.
0022-1899
10.1093/infdis/jiv020
Autor
Carvalho, Augusto M
Cristal, Juqueline Rocha
Muniz, Aline de Couto
Carvalho, Lucas Pedreira de
Gomes, Regis
Miranda, José Carlos
Barral, Aldina Maria Prado
Carvalho Filho, Edgar Marcelino
Oliveira, Camila Indiani de
Resumen
Leishmaniasis is caused by parasites transmitted to the vertebrate host by infected sand flies. During
transmission, the vertebrate host is also inoculated with sand fly saliva, which exerts powerful immunomodulatory
effects on the host’s immune response.
Methods. We conducted a prospective cohort analysis to characterize the human immune response to Lutzomyia
intermedia saliva in 264 individuals, from an area for cutaneous leishmaniasis (CL) caused by Leishmania
braziliensis.
Results. Antibodies were found in 150 individuals (56.8%); immunoglobulin G1 and G4 were the predominant
subclasses. Recall responses to salivary gland sonicate showed elevated production of interleukin 10 (IL-10), interleukin
13, interferon γ, CXCL9, and CCL2 compared with controls. CD4+CD25+ T cells, including Foxp3+ cells, were the main
source of IL-10. L. braziliensis replication was increased (P < .05) in macrophages cocultured with saliva-stimulated
lymphocytes from exposed individuals and addition of anti–IL-10 reverted this effect. Positive correlation between antibody
response to saliva and cellular response to Leishmania was not found. Importantly, individuals seropositive to
saliva are 2.1 times more likely to develop CL (relative risk, 2.1; 95% confidence interval, 1.07–4.2; P < .05).
Conclusions. Exposure to L. intermedia sand flies skews the human immune response, facilitating L. braziliensis
survival in vitro, and increases the risk of developing CL.